Scientific Databases: The Foundation of Evidence-Based Medicine and ResearchλScientific Databases: The Foundation of Evidence-Based Medicine and Research

The modern scientific ecosystem comprises over 15,000 specialized databases. Choosing the right platform determines the completeness of literature reviews and methodological correctness of research — an inappropriate database leads to systematic sampling errors and distorted conclusions.

Understanding the architecture and specialization of databases becomes a critical skill in conditions of information abundance.

Multidisciplinary Platforms as Universal Entry Points

Scopus and Web of Science are the most authoritative multidisciplinary platforms, indexing over 70 million documents from all fields of science. Scopus covers approximately 25,000 journals since 1996, providing scientometric analysis tools and real-time citation tracking.

Web of Science, existing since 1964, provides unique depth of retrospective search and is considered the gold standard for assessing scientific impact, though it requires institutional subscriptions costing up to $100,000 per year.

A critical limitation of both platforms is English-language dominance and insufficient representation of regional journals, creating systematic bias toward Western science.

Subject-Specialized Databases as Sources of Expert Content

PubMed remains the irreplaceable tool for medical and biological research, indexing over 35 million articles using the controlled MeSH vocabulary of 29,000 terms. The platform provides free access to abstracts and full-text open access articles, integrating systematic reviews and meta-analyses from the Cochrane Library — the highest level of medical evidence.

ArXiv, created for physics and mathematics, contains over 2 million preprints, allowing tracking of scientific discoveries months before official publication. Requires critical evaluation since materials do not undergo peer review.

Specialized Indexing

Chemical Abstracts Service uses over 100 million unique chemical structures for search — a depth unattainable for universal platforms.

Advantage of Specialized Databases

Provide subject indexing that universal platforms cannot achieve.

Open Repositories and National Databases

CyberLeninka represents the largest Russian-language open repository with over 3 million scientific articles, providing access to regional research absent from international databases. The eLIBRARY.RU platform integrates scientometric functions with full-text access, indexing over 38 million publications.

National databases are critically important for interdisciplinary research requiring consideration of local context — epidemiological data or sociological surveys are often published only in regional journals.

Open repositories demonstrate variable quality control: while PubMed Central requires peer review, institutional repositories may accept any materials without verification.

Evidence-based medicine establishes a strict pyramid of scientific evidence, where the methodological design of a study determines the reliability of its conclusions. Systematic reviews occupy the apex, synthesizing data from dozens of studies with combined samples of up to 100,000 patients, while case reports sit at the base due to their inability to be generalized.

Citing a single study instead of a systematic review can lead to erroneous clinical decisions with potentially lethal consequences.

Systematic Reviews and Meta-Analyses as the Gold Standard

Systematic reviews apply a rigorous protocol for searching, selecting, and analyzing all available studies on a specific question, minimizing the risk of systematic errors and publication bias. Meta-analysis complements systematic review by statistically combining results, increasing statistical power—an 8% reduction in mortality may only be statistically significant when pooling 20,000 patients.

A critical limitation of the method is dependence on the quality of source studies: a meta-analysis of poorly designed trials produces a precise but useless estimate of an incorrect effect.

The Cochrane Collaboration sets international standards for systematic reviews, requiring independent assessment by two reviewers, protocol registration before work begins, and mandatory updates every 2–3 years.

Randomized Controlled Trials as the Foundation of Causality

Randomized controlled trials (RCTs) use random allocation of participants between intervention and control groups, eliminating systematic differences and enabling establishment of causal relationships. Double-blind placebo-controlled RCTs are considered the most reliable design, as neither participants nor researchers know the group assignments.

1. Large multicenter RCTs with samples exceeding 10,000 patients provide sufficient statistical power to detect even small effects.
2. A 15% reduction in heart attack risk with aspirin use was proven in a study of 22,000 physicians.
3. High cost (up to $50 million for pharmaceutical trials) limits scalability.
4. Ethical constraints prevent study of harmful exposures.
5. Low external validity due to strict inclusion criteria.

Cohort Studies and Case Reports in the Evidence Hierarchy

Cohort studies observe groups of people with different exposures over time, allowing investigation of rare outcomes and long-term effects unavailable to RCTs. The link between smoking and lung cancer was established in a 50-year observation of British physicians.

Prospective cohorts provide higher quality data than retrospective ones, but require decades of observation and million-dollar budgets. Case reports and case series sit at the base of the evidence pyramid because they lack control groups, but remain valuable for identifying new diseases or unexpected side effects.

The evidence hierarchy is not absolute—a well-designed cohort study with 100,000 participants may be more reliable than a poorly executed RCT with 50 patients and high risk of systematic errors.

Professional searching in scientific databases requires a structured approach where each step is documented and can be reproduced by independent researchers. Suboptimal search strategies lead to two critical errors: missing relevant studies (low sensitivity) or retrieving thousands of irrelevant results (low specificity).

Systematic reviews require searching at least three databases using adapted strategies, since the overlap between PubMed and Embase results is only 50–60%.

Developing Search Strategies and Boolean Operators

An effective search strategy begins with formulating the research question in PICO format: Population, Intervention, Comparison, Outcome.

Example: "In patients with type 2 diabetes (P), does metformin (I) compared to placebo (C) reduce the risk of cardiovascular events (O)?"

Boolean operators combine search terms: OR expands the search within a concept (metformin OR glucophage), AND narrows between concepts (diabetes AND metformin), NOT excludes irrelevant results.

Using parentheses determines the order of operations: (diabetes OR "diabetes mellitus") AND (metformin OR glucophage) AND ("cardiovascular events" OR "heart attack" OR myocardial) ensures precise control over query logic.

Using MeSH Terms and Subject Headings

Medical Subject Headings (MeSH) is a controlled vocabulary of 29,000 terms organized in a hierarchical structure of 16 categories. Each article in PubMed is indexed with 10–15 of the most relevant descriptors.

Searching by MeSH terms ensures high precision because it automatically includes all subordinate terms—for example, searching "Neoplasms"[Mesh] will find articles indexed as "Breast Neoplasms", "Lung Neoplasms" and all 200+ tumor subtypes.

Qualifiers (subheadings)

Specify the aspect of study for a term. Example: "Diabetes Mellitus/drug therapy"[Mesh] limits results to only pharmacological treatment, excluding epidemiology and diagnosis.

Combined search

Combining MeSH search with text search in titles and abstracts provides optimal balance: ("Diabetes Mellitus"[Mesh] OR diabetes[tiab]) AND ("Metformin"[Mesh] OR metformin[tiab]) finds both indexed articles and recent publications not yet assigned MeSH terms.

Applying Filters and Search Limits

Publication type filters allow limiting results to systematic reviews and meta-analyses or RCTs—critically important for evidence-based medicine. In PubMed, the "Systematic Review"[pt] filter reduces 50,000 diabetes results to 3,000 of the most reliable sources.

Time limits should be applied with justification: for rapidly evolving fields, the last 3–5 years are relevant, whereas for fundamental questions, historical works remain current.

1. Language filters create systematic bias—excluding non-English publications can lead to missing up to 10% of relevant data, especially in epidemiological studies of regional diseases.
2. Documenting all applied filters is mandatory for reproducibility: "PubMed searched on 2024-01-15, filters: Systematic Review, Humans, English, 2019–2024, resulting in 247 articles".
3. Methodological transparency enables independent researchers to update the search.